Source: Eur Respir J, 55 (1) 1901333; 10.1183/13993003.01333-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jessica Rademacher, Stefanie Konwert, Jan Fuge, Sabine Dettmer, Tobias Welte, Felix C. Ringshausen. Anti-IL5 and anti-IL5Ra therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series. Eur Respir J, 55 (1) 1901333; 10.1183/13993003.01333-2019

Member's Comments

No comment yet.

Related content which might interest you: Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Response to benralizumab in severe eosinophilic asthma after intermediate-to-poor response to mepolizumab : a retrospective study. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Mepolizumab in real-life treatment of severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review Source: Eur Respir J 2014; 44: 382-393 Year: 2014 Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Real-life treatment of severe eosinophilic asthma with mepolizumab Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma Source: ERJ Open Res, 7 (4) 00465-2021; 10.1183/23120541.00465-2021 Year: 2021 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma Source: International Congress 2017 – Asthma management Year: 2017 Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Pulmonary bilateral infiltrates, eosinophilia, granulomatous skin lesions: clinical presentation in a particoular case of eosinophilic pneumonia toxocara canis IgG/IgM positive Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013